Insider Transactions in Q1 2021 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2021
|
Michael Bonner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-5.26%
|
$3,201
$3.22 P/Share
|
Mar 17
2021
|
Leo Pavliv SVP and Chief Development Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,870
-1.68%
|
$8,610
$3.22 P/Share
|
Mar 17
2021
|
James L Herman VP and Chief Compliance Office |
SELL
Payment of exercise price or tax liability
|
Direct |
2,560
-5.38%
|
$7,680
$3.22 P/Share
|
Mar 17
2021
|
A J Kazimi Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+0.21%
|
$36,000
$3.22 P/Share
|
Mar 17
2021
|
A J Kazimi Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,350
-0.64%
|
$112,050
$3.22 P/Share
|
Mar 17
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.59%
|
$3,000
$3.22 P/Share
|
Mar 17
2021
|
Joseph C Galante |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.99%
|
$3,000
$3.22 P/Share
|
Mar 17
2021
|
Jonathan Griggs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.33%
|
$3,000
$3.22 P/Share
|
Mar 17
2021
|
Joey A Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.83%
|
$15,000
$3.22 P/Share
|
Mar 17
2021
|
James Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.37%
|
$3,000
$3.22 P/Share
|
Mar 17
2021
|
Caroline Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+7.73%
|
$3,000
$3.22 P/Share
|
Mar 17
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,945
-1.94%
|
$8,835
$3.22 P/Share
|